Biopsy

A prostate biopsy, also known as a core needle biopsy or a transrectal ultrasound (TRUS), is used to determine if any suspicious looking tissues are cancerous or not. A biopsy is conducted when an abnormal lump is found during a digital rectal exam (DRE) or if the prostate-specific antigen (PSA) blood test reveals high levels of PSA.

Prostate Cancer Canada graciously acknowledges the Princess Margaret Cancer Centre for sharing this video with us.
 
How is a biopsy performed?
  • You will be given a local anesthetic. 
  • A biopsy needle and ultrasound probe is then inserted into your rectum. Your doctor will use the ultrasound as a visual aid to help him/her guide the needle through your rectum. The needle quickly pierces through the rectal wall, enters the prostate and removes a tissue sample.
  • 8-12 samples will be taken depending on the area to be examined.
  • Procedure lasts between 15 and 20 minutes. 
What can I expect after the procedure?
 
Everyone responds differently to procedures. Following a prostate biopsy, it is common to experience the following:
  • Bleeding from your rectum or penis
  • Blood in the stool, urine or semen
  • Pain
These common symptoms may persist for 2 weeks or more. If you have concerns about these symptoms, discuss them with your doctor.


 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More

Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More


Click here for news archive